Cytokine inhibition of the hepatitis B virus core promoter

Hepatology

Volumn 23, Issue 1, 1996, Pages 17-23

  Romero, René ^a,b   Lavine, Joel E ^a,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; LUCIFERASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BASE PAIRING; CELL VIABILITY; ENZYME ACTIVITY; GENE EXPRESSION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION; VIRUS CORE; VIRUS DNA CELL DNA INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0030065678     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008550037     Document Type: Article

References (24)

1. Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-1956.
2. Centers for Disease Control. Hepatitis surveillance. Atlanta, GA: Centers for Disease Control, 1990.
3. Thomas HC, Montano A, Goodal A, de Koning R, Oladapo J, Weidman KH. Immunological mechanisms in chronic hepatitis B infection. HEPATOLOGY 1982;2:S116-S121.
4. Bertoletti A, Ferrari C, Fiaccadori F, Penna A, Margolskee R, Schlicht HJ, Fowler P, et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci U S A 1991;88:10445-10449.
5. Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, Huang S, et al. Mechanisms of class I restricted immunopathology: a transgenic mouse model of fulminant hepatitis. J Exp Med 1993;178:1541-1554.
6. Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster RL, et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 1990;248:361-364.
7. Gilles PN, Fey G, Chisari FV. Tumor necrosis factor-alpha negatively regulates hepatitis B virus expression in transgenic mice. J Virol 1992;66:3955-3960.
8. Guidotti LG, Guilhot S, Chisari FV. Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways. J Virol 1994;68:1265-1270.
9. Guilhot S, Guidotti LG, Chisari FV. Interleukin-2 down regulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism. J Virol 1993;67:7444-7449.
10. Shaul Y, Rutter NJ, Laub O. A human hepatitis B viral enhancer element. EMBO J 1985;4:427-430.
11. Yee JK. A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science 1989;246:658-661.
12. Tur-Kaspa R, Shaul Y, Moore DD, Burk RD, Okret S, Poellinger L, Shafritz DA. The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology 1988;67:630-633.
13. Schaller H, Fischer M. Transcriptional control of hepadnavirus gene expression. Curr Topics Microbiol Immunol 1991;168:21-39.
14. Honigwachs J, Factor O, Dikstein R, Shaul Y, Laub O. Liver-specific expression of the hepatitis B virus is determined by the combined action of the core promoter and the enhancer. J Virol 1989;63:919-924.
15. Morrone G, Ciliberto G, Oliviero R, Arcone L, Dente J, Content J, Cortese R. Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. J Biol Chem 1988;263:12554-12558.
16. Gunter U, Arrone C, Toniatti G, Morrone G, Ciliberto G. Dual control of C reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J 1989;8:3773-3779.
17. Banerjee R, Karpen S, Siekewitz M, Lengyel G, Bauer J, Acs G. Tumor necrosis factor-alpha induces a kappa beta sequence-specific DNA binding protein in human hepatoblastoma HepG2 cells. HEPATOLOGY 1989;10:1008-1013.
18. Edbrooke MR, Burt DW, Chesire JK, Woo P. Identification of cis-acting sequence responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor κB transcription factor. Mol Cell Biol 1989;9:1908-1916.
19. Ron D, Brasier AR, Wright K, Habener JF. The permissive role of glucocorticoids on interleukin-1 stimulation of angiotensinogen gene transcription is mediated by interaction between inducible enhancers. Mol Cell Biol 1990;10:4389-4395.
20. Penna A, Chisari FV, Bertoletti A, Missale G, Fowler P, Guiberti T, Fiaccadori F, et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991;174:1565-1570.
21. Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht HJ, Ferrari C, et al. HLA-A31 and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 1993;177:751-762.
22. Bertoletti A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A, Penna A, et al. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 1994;180:933-943.
23. Sambrooke J, Fritsch EF, Maniatis T. Molecular cloning. Ed 2. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989.
24. Bruss V, Ganem D. The role of envelope proteins in hepatitis B virus envelope assembly. Proc Natl Acad Sci U S A 1991;88:1059-1063.